These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17034119)

  • 41. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10.
    Rubic T; Lorenz RL
    Cardiovasc Res; 2006 Feb; 69(2):527-35. PubMed ID: 16336952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A cholesterol-free, high-fat diet suppresses gene expression of cholesterol transporters in murine small intestine.
    de Vogel-van den Bosch HM; de Wit NJ; Hooiveld GJ; Vermeulen H; van der Veen JN; Houten SM; Kuipers F; Müller M; van der Meer R
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1171-80. PubMed ID: 18356535
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physical and functional interactions between liver X receptor/retinoid X receptor and Sp1 modulate the transcriptional induction of the human ATP binding cassette transporter A1 gene by oxysterols and retinoids.
    Thymiakou E; Zannis VI; Kardassis D
    Biochemistry; 2007 Oct; 46(41):11473-83. PubMed ID: 17887732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARgamma-LXRalpha-ABCA1-dependent pathway associated with apoE.
    Hou M; Xia M; Zhu H; Wang Q; Li Y; Xiao Y; Zhao T; Tang Z; Ma J; Ling W
    Cell Biochem Funct; 2007; 25(1):33-44. PubMed ID: 16981222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner.
    Hao XR; Cao DL; Hu YW; Li XX; Liu XH; Xiao J; Liao DF; Xiang J; Tang CK
    Atherosclerosis; 2009 Apr; 203(2):417-28. PubMed ID: 18789440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317.
    Eckert GP; Vardanian L; Rebeck GW; Burns MP
    Neurosci Lett; 2007 Aug; 423(1):47-52. PubMed ID: 17662526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination of virtual screening and high throughput gene profiling for identification of novel liver X receptor modulators.
    Cheng JF; Zapf J; Takedomi K; Fukushima C; Ogiku T; Zhang SH; Yang G; Sakurai N; Barbosa M; Jack R; Xu K
    J Med Chem; 2008 Apr; 51(7):2057-61. PubMed ID: 18324758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Research progress of liver X receptor agonists].
    Liang Y; Guo CB; Zhang C; Hou ZG
    Yao Xue Xue Bao; 2012 Apr; 47(4):427-33. PubMed ID: 22799022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1-(3-Aryloxyaryl)benzimidazole sulfones are liver X receptor agonists.
    Travins JM; Bernotas RC; Kaufman DH; Quinet E; Nambi P; Feingold I; Huselton C; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem Lett; 2010 Jan; 20(2):526-30. PubMed ID: 20006495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Synthesis of (24S)-hydroxy- and (24S)-24,25-epoxycholesterol analogues, potential agonists of nuclear LXR receptors].
    Khripach VA; Zhabinskiĭ VN; Antonchik AV; Antonchik AP
    Bioorg Khim; 2006; 32(6):651-9. PubMed ID: 17180916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery and optimization of a novel series of liver X receptor-alpha agonists.
    Li L; Liu J; Zhu L; Cutler S; Hasegawa H; Shan B; Medina JC
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1638-42. PubMed ID: 16386417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 6-Substituted quinolines as RORγt inverse agonists.
    Barbay JK; Cummings MD; Abad M; Castro G; Kreutter KD; Kummer DA; Maharoof U; Milligan C; Nishimura R; Pierce J; Schalk-Hihi C; Spurlino J; Tanis VM; Urbanski M; Venkatesan H; Wang A; Woods C; Wolin R; Xue X; Edwards JP; Fourie AM; Leonard K
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5277-5283. PubMed ID: 29079472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity.
    Pellicciari R; Fiorucci S; Camaioni E; Clerici C; Costantino G; Maloney PR; Morelli A; Parks DJ; Willson TM
    J Med Chem; 2002 Aug; 45(17):3569-72. PubMed ID: 12166927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Crystal structure of the human liver X receptor beta ligand-binding domain in complex with a synthetic agonist.
    Hoerer S; Schmid A; Heckel A; Budzinski RM; Nar H
    J Mol Biol; 2003 Dec; 334(5):853-61. PubMed ID: 14643652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2 H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors.
    Sliskovic DR; Picard JA; Roark WH; Roth BD; Ferguson E; Krause BR; Newton RS; Sekerke C; Shaw MK
    J Med Chem; 1991 Jan; 34(1):367-73. PubMed ID: 1992138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources.
    Jayasuriya H; Herath KB; Ondeyka JG; Guan Z; Borris RP; Tiwari S; de Jong W; Chavez F; Moss J; Stevenson DW; Beck HT; Slattery M; Zamora N; Schulman M; Ali A; Sharma N; MacNaul K; Hayes N; Menke JG; Singh SB
    J Nat Prod; 2005 Aug; 68(8):1247-52. PubMed ID: 16124770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a 2-phenyl-substituted octahydrobenzo[f]quinoline as a dopamine D₃ receptor-selective full agonist ligand.
    Clark AH; McCorvy JD; Conley JM; Williams WK; Bekkam M; Watts VJ; Nichols DE
    Bioorg Med Chem; 2012 Nov; 20(21):6366-74. PubMed ID: 23018094
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility.
    Nomura S; Endo-Umeda K; Fujii S; Makishima M; Hashimoto Y; Ishikawa M
    Bioorg Med Chem Lett; 2018 Feb; 28(4):796-801. PubMed ID: 29398545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches.
    Xiao HY; Li N; Duan JJ; Jiang B; Lu Z; Ngu K; Tino J; Kopcho LM; Lu H; Chen J; Tebben AJ; Sheriff S; Chang CY; Yanchunas J; Calambur D; Gao M; Shuster DJ; Susulic V; Xie JH; Guarino VR; Wu DR; Gregor KR; Goldstine CB; Hynes J; Macor JE; Salter-Cid L; Burke JR; Shaw PJ; Dhar TGM
    J Med Chem; 2020 Dec; 63(23):15050-15071. PubMed ID: 33261314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential antifertility agents. 7. Synthesis and biological activities of 2-,3-, and 6-alkyl-substituted 4-aryl-2-methylcyclohexanecarboxylic acids.
    Crenshaw RR; Luke GM; Jenks TA; Bialy G
    J Med Chem; 1974 Dec; 17(12):1262-8. PubMed ID: 4372352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.